New drug interaction study aims to make radiprodil safer for future use
NCT ID NCT06975605
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested how the experimental drug radiprodil interacts with five common medications (warfarin, midazolam, digoxin, rosuvastatin, and omeprazole) in 18 healthy adults. Participants took radiprodil alone and then with each of these drugs to measure changes in drug levels and safety. The goal is to understand if radiprodil affects how the body processes other drugs, which is important for planning future trials in people with tuberous sclerosis complex and other neurological disorders.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- radiprodil
- What this could lead to
- If successful, this study will help doctors understand how radiprodil interacts with other drugs, leading to safer dosing in future trials for neurological conditions.
- What could go wrong
- This is a very early, small study in healthy volunteers, not patients. It only checks drug interactions, not whether radiprodil works for any disease. Results may not predict effects in people with the target conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOCAL CORTICAL DYSPLASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nucleus Network Melbourne
Melbourne, Victoria, 3004, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Study links gum health to rare kidney diseases
- New drug radiprodil tested for tough seizures in two brain conditions
- Cannabis oil trial aims to tame seizures in rare genetic disorder
- New drug combo targets Hard-to-Treat cancers in early trial
- 20-Year study tests precision medicine for rare Brain-Skin disorders
- New pill aims to tame seizures in rare brain disorders